Koshland Pharmacy Inc

Alexza Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The company's technology, the Staccato system, vaporizes unformulated drug compound to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. Alexza Pharmaceuticals has four product candidates in clinical development: AZ-001 (Staccato prochlorperazine) for the treatment of acute migraine headaches; AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder; AZ-004 (Staccato loxapine) for the treatment of acute agitation in patients with schizophrenia; and AZ-003 (Staccato fentanyl) for the treatment of patients with acute pain. Alexza Pharmaceuticals is located in Palo Alto, Calif.

Shockwave Medical, based in Santa Clara, CA, is a leading medical technology company that specializes in the development and manufacturing of innovative devices for the treatment of calcified cardiovascular disease. Their Intravascular Lithotripsy (IVL) technology offers a unique mechanism of action that safely modifies calcium while reducing the risk of complications, making procedures more predictable and efficient. With a focus on both peripheral and coronary applications, Shockwave Medical's IVL technology has been proven to achieve low residual stenosis across multiple vessel beds, disrupting superficial and deep calcium. Their cutting-edge devices, such as the Shockwave C2 and L6, provide healthcare professionals with intuitive and effective tools to address the challenges of calcium in various cardiovascular conditions.Generated from the website